Latest news
NVO Stock Slumps After Late-Stage Trial Fails Primary Goal – Retail Says ‘Current Revenue Drivers’ Still Intact - stocktwits.comstocktwits.com · Sat, 08 Aug 2026 08:58:43 GMTNMRA Stock On Track For Worst Day In 1.5 Years — Neumora Therapeutics' Lead Depression Drug Fails Late Stage Trials - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 11:40:20 GMTNovo Nordisk (NYSE:NVO) Ziltivekimab Trial Fails In Late Stage Cardiovascular Study - simplywall.stsimplywall.st · Sat, 01 Aug 2026 07:00:00 GMTNovo Nordisk’s anti-inflammatory drug fails to reduce cardiovascular risk in late-stage trial - SRN NewsSRN News · Fri, 31 Jul 2026 12:41:25 GMTNovo drug trial fail deals setback to bid to expand beyond obesity - ReutersReuters · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline - CNBCCNBC · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk drops as anti-inflammatory drug fails in late-stage trial - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMT